Borosil Scientific has reported its third-quarter financial results, showing declines across key profitability metrics compared to the same period last year. The company's performance reflects challenging operating conditions that impacted both bottom-line earnings and operational efficiency.

Financial Performance Overview

The company's financial metrics for the third quarter demonstrated a mixed performance with declines in both net profitability and operational efficiency measures.

Profitability Analysis

The company's net profit for the third quarter stood at 241 million rupees, marking a substantial decrease of 113 million rupees from the previous year's corresponding quarter. This represents a significant 32% year-on-year decline in bottom-line performance.

Operational Efficiency Metrics

Borosil Scientific's EBITDA performance also showed a decline, with the metric reaching 529M rupees compared to 543M rupees in the same quarter last year. The EBITDA margin compressed to 15.6% from 16.1% in the previous year, indicating pressure on operational efficiency and profitability at the earnings level.

The decline in both absolute EBITDA and margin suggests that the company faced challenges in maintaining its operational leverage during the quarter, with costs potentially rising faster than revenue growth or revenue itself declining.

Borosil Scientific Limited has announced that CARE Ratings Limited has reaffirmed the company's credit ratings, demonstrating continued confidence in its financial stability. The rating agency issued a press release on December 9, 2025, confirming the reaffirmation of ratings for the company's banking facilities.

Credit Rating Details

CARE Ratings has maintained its assessment of Borosil Scientific Limited's creditworthiness across different facility categories. The rating reaffirmation covers both long-term and short-term banking facilities, providing clarity on the company's credit profile.

Facility Amount Adjustments

The rating reaffirmation comes alongside notable changes in facility amounts. The long-term bank facilities have been reduced to ₹0.53 crores from the previous ₹2.10 crores. Conversely, the combined long-term and short-term bank facilities have been enhanced to ₹99.47 crores from ₹97.90 crores, representing an increase in the company's available banking facilities.

Rating Significance

The CARE A- rating with stable outlook for long-term facilities indicates adequate degree of safety regarding timely servicing of financial obligations. The CARE A1 rating for short-term facilities reflects strong degree of safety regarding timely payment of financial obligations. The stable outlook suggests that the rating is unlikely to change in the near term.

Regulatory Compliance

Borosil Scientific Limited received this information on December 10, 2025, at approximately 3:45 p.m. The company has disclosed this development in accordance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The detailed credit rating rationale is available on CARE's website for stakeholders seeking comprehensive analysis of the rating decision.